Healthcare News by GLG Council Members
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
-
November 3, 2009
Deficit Plays into Health Reform | www.washingtonpost.com
There is no doubt that a great deal of time, efforts and resources have gone into trying to find a solution to the healthcare problems and concerns that we deal with today. What is not as clear to those who really need these problems solved are the answers thus far. A lot of very smart people seem to have forgotten the actual value of a person. What ever numbers show up on the balance sheet hardly provides any direction to those who care more about dollars and cents than common sense.
-
Eric WhitmanMedical Director, Office of Grants and ResearchATLANTIC HEALTH SYSTEM INC
Synta Drug for Metastatic Melanoma Not Dead Yet (?)
November 3, 2009
Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII | www.businesswire.com
Updated data presented at an annual Melanoma conference suggests the drug Elesclomol may benefit a subset of patients treated on a Phase III trial. This Synta Pharmaceuticals-sponsored trial in metastatic melanoma patients was stopped for safety (survival) concerns in February 2009, but the updated analysis suggests that a commonly available biomarker may identify patients who appear to benefit from Elesclomol treatment.This news is important because it may allow Synta to continue to pursue approval for Elesclomol in either melanoma patients or in other cancers. They will report an updated survival analysis twelve months after the protocol was stopped, after February 2010. Further info from Synta is expected soon.
-
Pharma Outsourcing: Where Will it End?
November 3, 2009
Quintiles inks pharma deals | www.outsourcing-pharma.com
A major supplier of clinical development services has just been awarded all of Astra Zeneca's clinical pharmacology work. Such work was traditionally performed internally but is now one of many stages of development being outsourced. This follows similar trends in research, where pharma companies are forging external relationships. We question where the pharma industry is headed and how much of its core business will remain in-house.
-
Eric WhitmanMedical Director, Office of Grants and ResearchATLANTIC HEALTH SYSTEM INC
Delcath Phase III trial for metastatic melanoma completes enrollment
November 3, 2009
Delcath Systems, Inc. Completes Phase III Study Enrollment | www.reuters.com
The Delcath Systems Percutaneous Hepatic Perfusion (PHP) trial to treat patients with metastatic melanoma has completed enrollment and now must track patients, record data, and analyze results.This trial was apparently enrolled on schedule and the company is targeting 2010 for FDA regulatory submission.
-
Ken PowellPresidentGenesis Business Development, LLC
Liquid-Based Cytology Found Not Superior to Conventional PAP
November 3, 2009
Alternative to Pap Test Does Not Appear to Be Better for Detecting Cervical Cancer | www.medcompare.com
A recent 90,000 patient, randomized Dutch study published in the Journal of American Medicine's October 28 issue found that liquid-based cytology is not superior to conventional Pap methods in sensitivity and specificity for cervical cancer detection. There are two leading US companies that provide liquid-based sample collection, transport and processing systems for cervical cancer screening.
-
Healthy if You're Wealthy: Ghana offers Choices
November 2, 2009
Ghana targets health tourism boom | news.bbc.co.uk
Article provides a spa in Ghana as an example of a boom in health tourism to that country. Medical tourism is popular already but many of those seeking care come from countries with less well developed services and tend to visit Western hospitals, rather than the reverse. There remains a need for basic health care services in Ghana (and elsewhere) but this does not seem to cater for any but the affluent.
-
ASTRO/ACRO help win the fight against Reimbursement Cuts for Radiation Oncology
November 2, 2009
CMS announcement regarding Radiation Oncology Reimbursement for 2010 | cs.astro.org
Major news breaking.. CMS has decided to implement only a 1% cut annually for radiation oncology reimbursement. This may be the most important news item in the world of oncology for the past decade. Faced with untenable projected cut of 19%, CMS reversed course and reduced the reduction in payment.
-
Ghana Targets Health Tourism Boom: More Evidence of Globalization
October 31, 2009
Ghana targets health tourism boom | news.bbc.co.uk
Just as high tech products are manufactured in Asian countries for a fraction of the cost, medical procedures will be provided in less developed countries for a fraction of the cost in the not so distant future.It will initially be low tech procedures such as cosmetic operations and minor procedures and will go on to more complex procedures like orthopedic and cardiac surgeries.
-
Ken PowellPresidentGenesis Business Development, LLC
Beckman Coulter Posts Strong 3Q Revenue Growth
October 31, 2009
Beckman Coulter Posts 8 Percent Q3 Growth on Strong Recurring Revenue | www.genomeweb.com
Beckman Coulter reported strong 3Q revenue growth of 8% compared to 3Q 08. Clinical diagnostics led the way, while cash instrument, cellular analysis and life science segment sales declined.
-
It's Time for Health Care Reform--Not Just Health Insurance Reform!
October 30, 2009
The Health Care Reform Debate We Need | blog.nj.com
With so much emphasis on changing the health insurance system, the far greater need to change the delivery and financing of care has gotten relatively little mention, at least in the sound bites where most people receiving their daily news. We should not squander this once in a lifetime change for real health care, and not just health insurance reform.
- Subscribe to Updates
-
Leading institutions connect with members of the Healthcare councils through GLG
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 7 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Most Popular Healthcare News
-
What is potential future for Sequenom in prenatal testing.
November 9, 2009
-
November 7, 2009
-
Express Scripts feeling Growing Pains
October 29, 2009
-
CDC Outlines H1N1 Test Guidelines
October 8, 2009
-
Why Health Care Costs Keep Rising—And What to Do About It
September 13, 2009